Superoxide dismutase: Master and commander?

European Respiratory Journal

Volumn 36, Issue 2, 2010, Pages 234-236

  Weir, E K ^a   Hong, Z ^b   Chen, Y ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYLARGININASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROGEN PEROXIDE; N(G),N(G) DIMETHYLARGININE; SUPEROXIDE; SUPEROXIDE DISMUTASE; TETRAHYDROBIOPTERIN;

ANTIOXIDANT ACTIVITY; BLOOD VESSEL REACTIVITY; EDITORIAL; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SIGNAL TRANSDUCTION; VASODILATATION;

ANIMALS; HUMANS; HYDROGEN PEROXIDE; HYPERTENSION, PULMONARY; LUNG; MICE; NITRIC OXIDE; RATS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; SUPEROXIDE DISMUTASE; VASODILATOR AGENTS;

EID: 77955610143     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00062510     Document Type: Editorial

References (29)

1. Girgis R, Champion H, Diette G, et al. Decreased exhaled nitric oxide in pulmonary aterial hypertension: response to bosentan therapy. Am J Respir Crit Care Med 2005; 172: 262-263.
2. Demoncheaux E, Higenbottam T, Kiely D, et al. Decreased whole body endogenous nitric oxide production in patients with primary pulmonary hypertension. J Vasc Res 2005; 42: 133-136. (Pubitemid 41201978)
3. Archer S, Djaballah K, Humbert M, et al. Nitric oxide deficiency in fenfluramine- and dexfenfluramine- induced pulmonary hypertension. Am J Respir Crit Care Med 1998; 158: 1061-1067. (Pubitemid 28489002)
4. Dollberg S, Warner B, Myatt L. Urinary nitrite and nitrate concentrations in patients with idiopathic persistent pulmonary hypertension of the newborn and effect of extracorporeal membrane oxygenation. Pediatr Res 1995; 36: 31-34.
5. Giaid A, Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med 1995; 333: 214-221.
6. Villanueva M, Zaher F, Svinarich D, et al. Decreased gene expression of endothelial nitric oxide synthase in newborns with persistent pulmonary hypertension. Pediatr Res 1998; 44: 337-343.
7. Kielstein J, Bode-Böger S, Hesse G, et al. Asymmetrical dimethyl-arginine in idiopathic pulmonary arterial hypertension. Arterioscler Thromb Vasc Biol 2005; 25: 1414-1418. (Pubitemid 40923361)
8. Hu X, Xu X, Zhu G, et al. Vascular endothelial-specific dimethylarginine dimethlyaminohydrolase-1 -deficient mice reveal that vascular endothelium plays an important role in removing asymmetric dimethylarginine. Circulation 2009; 120: 2222-2229.
9. Sasaki A, Doi S, Mizutani S, et al. Roles of accumulated endogenous nitric oxide synthase inhibitors, enhanced arginase activity, and attenuated nitric oxide synthase activity in endothelial cells for pulmonary hypertension in rats. Am J Physiol Lung Cell Mol Physiol 2007; 292: L1480-1487.
10. Mehta S, Stewart D, Langleben D, et al. Short-term pulmonary vasodilation with L-arginine in pulmonary hypertension. Circulation 1995; 92: 1539-1545.
11. Nagaya N, Uematsu M, Oya H, et al. Short-term oral administration of L-arginine improves hemodynamics and exercise capacity in patients with precapillary pulmonary hypertension. Am J Respir Crit Care Med 2001; 163: 887-891.
12. Nandi M, Miller A, Stidwill R, et al. Pulmonary hypertension in a GTP-cyclohydrolase 1-deficient mouse. Circulation 2005; 111: 2086-2090.
13. Khoo J, Zhao L, Alp N, et al. Pivotal role for endothelial tetrahydrobiopterin in pulmonary hypertension. Circulation 2005; 111: 2126-2133.
14. Francis BN, Wilkins MR, Zhao L. Tetrahydrobiopterin and the regulation of hypoxic pulmonay vasoconstriction. Eur Respir J 2010; 36: 323-330.
15. 2. In: Lahiri S, ed. Oxygen Sensing: Molecule to Man. New York, Kluwer Academic/Plenum Publishers, 2000; pp. 249-258.
16. Michelakis E, Hampl V, Nsair A, et al. Diversity in mitochodrial function explains differences in vascular oxygen sensing. Circ Res 2002; 90: 1307-1315.
17. Weir E, Lopez-Barneo J, Buckler K, et al. Acute oxygen-sensing mechanisms. N Engl J Med 2005; 353: 2042-2055.
18. Wolin M. Reactive oxygen species and the control of vascular function. Am J Physiol Heart Circ Physiol 2009; 296: H539-H549.
19. Veal E, Day A, Morgan B. Hydrogen peroxide sensing and signaling. Molecular Cell 2007; 26: 1-14.
20. 2-mediates oxidation and inactivation of phosphatases in growth factor signaling. PNAS 2008; 105: 7147-7152.
21. Williams M, Van Remmen H, Conrad C, et al. Increased oxidative damage is correlated to altered mitochondrial function in heterozygous manganase superoxide dismutase knockout mice. J Biol Chem 1998; 273: 28510-28515.
22. Hodyc D, Snorek M, Brtnicky T, et al. Superoxide dismutase mimetic tempol inhibits hypoxic pulmonary vasoconstriction in rats independently of nitric oxide production. Exp Physiol 2007; 92: 945-951.
23. Konduri G, Bakhutashvili I, Els A, et al. Oxidant stress from uncoupled nitric oxide synthase impairs vasodilation in fetal lambs with persistent pulmonary hypertension. Am J Physiol Heart Circ Physiol 2007; 292: H1812-H1820.
24. Archer S, Will J, Weir E. Redox status in the control of pulmonary vascular tone. Herz 1986; 11: 127-141.
25. Ahmad M, Zhao X, Kelly M, et al. Heme oxygenase- 1 induction modulates hypoxic pulmonary vasoconstriction through upregulation of ecSOD. Am J Physiol Heart Circ Physiol 2009; 297: H1453-H1461.
26. Bonnet S, Michelakis E, Porter C, et al. An abnormal mitochondrial- hypoxia inducible factor-1α-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats. Similiarities to human pulmonary arterial hypertension. Circulation 2006; 113: 2630-2641.
27. Elmedal B, de Dam M, Mulvany M, et al. The superoxide disutase mimetic, tempol, blunts right ventricular hypertrophy in chronic hypoxic rats. Br J Pharmacol 2004; 141: 105-113.
28. Farrow K, Lakshminrusimha S, Reda WJ, et al. Superoxide dismutase restores eNOS expression and function in resistance pulmonary arteries from neonatal lambs with persistent pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2008; 295: L979-L987.
29. Katusic Z, d'Uscio L, Nath K. Vascular protection by tetrahydrobiopterin: progress and therapeutic prospects. Trends Pharmacol Sci 2009; 39: 48-54.